Drugs / Acemetacin
Acemetacin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT07582146 | Apr → Sep 2026 overdue | ankylosing spondylitis | Chinese PLA General Hospital | Not yet recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT04685291 Comparator | Apr 2021 → Jun 2023 | — | Eckehart SCHÖLL | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acemetacin | “oral pain medication in patients older than or equal 70 years: Acemetacin 60mg (1-1-1) AND Metamizole 500mg (max. 2 tbl. every 6 hours)” NCT04685291 ↗ |
| Known as | Acemetacina | ChEMBL registry synonym — accepted as the source's own label CHEMBL189171 ↗ |
| Known as | Acemetacine | ChEMBL registry synonym — accepted as the source's own label CHEMBL189171 ↗ |
| Known as | Emflex | ChEMBL registry synonym — accepted as the source's own label CHEMBL189171 ↗ |
| Known as | NSC-757413 | ChEMBL registry synonym — accepted as the source's own label CHEMBL189171 ↗ |
| Known as | Rantudil | ChEMBL registry synonym — accepted as the source's own label CHEMBL189171 ↗ |
| Modality | Small molecule | “Acemetacin is a non-steroidal anti-inflammatory drug (NSAID) belonging to the indole derivative class” NCT07582146 ↗ |
| Route | Oral | “oral pain medication in patients older than or equal 70 years: Acemetacin” NCT04685291 ↗ |